
Global Equine Fluid Therapy Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2026
5407
Jan 2022
178
PDF
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
MarketResearch.biz delivers in-depth insights on the global equine fluid therapy market in its upcoming report titled, “Global Equine Fluid Therapy Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global equine fluid therapy market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global equine fluid therapy market report has been segmented on the basis of route of administration, fluid type, end user, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Equine fluid is hypotonic and contains a higher concentration of potassium. Equine fluids are primarily used as foundations for treatments in equine by medical practitioners. The equine fluid therapy is provided to both adult horses and foals.
Increasing adoption of pets in developed and developing economies and increasing breeding of horses across developed economies are major factors driving growth of the global equine fluid therapy market. In addition, increasing incidence of equine infections and development of advanced veterinary medical care facilities across developed economies are other major factors expected to boost growth of the global equine fluid therapy market over the forecast period.
However, high costs associated with equine fluid therapies is a major factor restraining growth of the global market. Additionally, lack of skilled medical professionals coupled with limited availability of advanced medical care facilities in developing economies are other major factors expected to hamper growth of the global equine fluid therapy market over the forecast period.
Currently, the market in North America accounts for highest share in the global equine fluid therapy market in revenue terms, owing to growing awareness about animal health and presence of proper medical infrastructure in the region. The market in Europe accounted for second-highest revenue share in the global equine fluid therapy market, due to high disposable income and increasing government initiatives for spreading awareness about animal health, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increase incidence of equine infections, and rise in government initiatives for improvement of healthcare facilities in the region. Moreover, the markets in Latin America and Middle East & Africa are expected to witness moderate growth over the forecast period. Also, revenue from the market in Middle East & Africa is projected to register a CAGR of X.X% over the forecast period.
Global equine fluid therapy market segmentation:
By route of administration:
- Intravenous
- Enteral
By fluid type:
- Crystalloids
- Colloids
- Combination
By end user:
- Hospitals
- Veterinary Clinics
- Diagnostic Centers
- Others
By region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn - MAI Animal Health
- Dechra Pharmaceuticals Plc.
- Zoetis Services LLC
- Merck Animal Health
- Abbott Laboratories
- Luitpold Pharmaceuticals, Inc.
- Hospira Inc.
- Vedco Inc.
- Muddy & Inca.
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!